Utah Medical Products, Inc. (UTMD) Balance Sheet
UTMD balance sheet, 2025
December 31, 2025 · U.S. dollars$122.5M assets = $3.3M liabilities + $119.3M equity
Both columns are drawn to the same scale: what UTMD owns equals what it owes plus shareholders’ equity. Hover a block for its value.
UTMD financial health
Descriptive bands, not a rating. Fiscal 2025.
UTMD balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $76.6M2016 | $122.5M2025 | +5.4%/yr | |
| Total liabilities | $7.3M2016 | $3.3M2025 | −8.6%/yr | |
| Shareholders’ equity | $69.2M2016 | $119.3M2025 | +6.2%/yr | |
| Cash & short-term investments | $26.4M2016 | $85.8M2025 | +14.0%/yr | |
| Total debt | $376,0002019 | $225,0002025 | −8.2%/yr | |
| Net cash (debt) | $42.4M2019 | $85.5M2025 | +$43.1M | |
| Working capital | $31.8M2016 | $95.1M2025 | +$63.3M | |
| Book value per share | $18.382016 | $36.812025 | +8.0%/yr | |
| Debt / equity | 0.002019 | 0.002025 | 0.00 | |
| Shares outstanding | 3.8M2016 | 3.2M2025 | −1.7%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
UTMD assets
UTMD liabilities and equity
UTMD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
UTMD balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $85.8M | $83.0M | $92.9M | $75.1M | $61.0M | $51.6M | $42.8M | $51.1M | $40.0M | $26.4M |
| Cash & equivalents | $85.8M | $83.0M | $92.9M | $75.1M | $61.0M | $51.6M | $42.8M | $51.1M | $39.9M | $26.4M |
| Short-term investments | — | — | $185.7M | — | — | — | — | $0 | $80,000 | $64,000 |
| Receivables | $3.5M | $4.1M | $3.4M | $5.5M | $5.1M | $4.1M | $4.7M | $4.0M | $3.6M | $3.2M |
| Inventory | $7.9M | $8.8M | $9.6M | $8.8M | $6.6M | $6.2M | $6.9M | $5.4M | $5.2M | $4.5M |
| Other current assets | $529,000 | $449,000 | $429,000 | $515,000 | $457,000 | $346,000 | $443,000 | $422,000 | $366,000 | $754,000 |
| Total current assets | $97.7M | $96.3M | $106.3M | $89.9M | $73.2M | $62.3M | $54.9M | $60.9M | $49.2M | $34.9M |
| Property, plant & equipment (net) | $9.9M | $9.8M | $10.6M | $10.2M | $10.6M | $11.3M | $10.7M | $10.4M | $11.6M | $10.0M |
| Goodwill & intangible assets | $14.9M | $16.4M | $18.6M | $23.7M | $31.9M | $38.2M | $44.2M | $28.5M | $31.9M | $31.8M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $122.5M | $122.5M | $135.5M | $123.9M | $115.6M | $111.7M | $109.8M | $99.8M | $92.7M | $76.6M |
| Liabilities | ||||||||||
| Accounts payable | $911,000 | $543,000 | $769,000 | $1.2M | $761,000 | $788,000 | $1.1M | $975,000 | $934,000 | $906,000 |
| Short-term debt | — | $56,000 | $47,000 | $54,000 | $52,000 | $41,000 | $38,000 | — | — | — |
| Deferred revenue | — | — | $327,000 | −$54,000 | −$52,000 | −$41,000 | −$38,000 | — | — | — |
| Total current liabilities | $2.6M | $3.8M | $4.7M | $6.0M | $3.7M | $3.8M | $3.4M | $5.3M | $5.3M | $3.0M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $225,000 | $282,000 | $295,000 | $341,000 | $331,000 | $335,000 | $376,000 | — | — | — |
| Other long-term liabilities | $676,000 | $1.4M | $2.4M | $3.7M | $4.8M | $5.1M | $5.2M | $5.5M | $9.3M | $4.3M |
| Total liabilities | $3.3M | $5.1M | $7.1M | $9.6M | $8.5M | $8.9M | $8.7M | $10.8M | $14.6M | $7.3M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $32,000 | $33,000 | $36,000 | $36,000 | $37,000 | $36,000 | $37,000 | $37,000 | $37,000 | $37,000 |
| Retained earnings (deficit) | $128.7M | $129.3M | $138.3M | $126.0M | $115.3M | $111.0M | $110.8M | $100.1M | $85.6M | $81.1M |
| Treasury stock | — | — | — | — | — | — | — | — | $0 | $0 |
| Accumulated other comprehensive income | −$9.4M | −$11.9M | −$10.7M | −$12.0M | −$9.1M | −$8.3M | −$9.8M | −$11.3M | −$8.3M | −$12.2M |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $119.3M | $117.4M | $128.3M | $114.3M | $107.1M | $102.8M | $101.1M | $89.0M | $78.1M | $69.2M |
| Key figures | ||||||||||
| Total debt | $225,000 | $338,000 | $295,000 | $341,000 | $396,000 | $335,000 | $376,000 | — | — | — |
| Net cash (debt) | $85.5M | $82.6M | $92.6M | $74.7M | $60.6M | $51.3M | $42.4M | — | — | — |
| Working capital | $95.1M | $92.6M | $101.6M | $84.0M | $69.4M | $58.5M | $51.4M | $55.6M | $43.9M | $31.8M |
| Tangible book value | $104.4M | $101.0M | $109.7M | $90.5M | $75.3M | $64.7M | $56.9M | $60.5M | $46.2M | $37.5M |
| Book value per share | $36.81 | $33.52 | $35.28 | $31.36 | $29.27 | $28.00 | $27.04 | $23.74 | $20.91 | $18.38 |
| Shares outstanding | 3.2M | 3.5M | 3.6M | 3.6M | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | 3.8M |
| Current ratio | 37.62 | 25.64 | 22.56 | 15.09 | 19.53 | 16.42 | 15.92 | 11.58 | 9.32 | 11.54 |
| Quick ratio | 34.36 | 23.18 | 20.44 | 13.52 | 17.65 | 14.69 | 13.78 | 10.47 | 8.25 | 9.79 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| Equity / assets | 97.3% | 95.8% | 94.7% | 92.2% | 92.7% | 92.0% | 92.1% | 89.2% | 84.2% | 90.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $87.5M | $87.4M | $85.8M | $84.3M | $82.2M | $83.3M | $83.0M | $88.5M | $89.2M | $93.8M | $92.9M | $88.2M |
| Cash & equivalents | $87.5M | $87.4M | $85.8M | $84.3M | $82.2M | $83.3M | $83.0M | $88.5M | $89.2M | $93.8M | $92.9M | −$305,000 |
| Short-term investments | $87.5M | — | — | — | — | — | — | — | $178.4M | $187.6M | $185.7M | $88.5M |
| Receivables | $3.6M | $3.6M | $3.5M | $3.7M | $3.6M | $3.9M | $4.1M | $3.7M | $3.7M | $3.6M | $3.4M | $3.5M |
| Inventory | $9.0M | $8.7M | $7.9M | $8.1M | $8.2M | $8.6M | $8.8M | $9.1M | $9.1M | $9.2M | $9.6M | $9.7M |
| Other current assets | $543,000 | $614,000 | $529,000 | $422,000 | $331,000 | $482,000 | $448,000 | $377,000 | $377,000 | $510,000 | $429,000 | $442,000 |
| Total current assets | $100.6M | $100.4M | $97.7M | $96.5M | $94.4M | $96.4M | $96.3M | $101.7M | $102.3M | $107.1M | $106.3M | $101.8M |
| Property, plant & equipment (net) | $9.6M | $9.7M | $9.9M | $10.0M | $10.3M | $9.9M | $9.8M | $10.4M | $10.2M | $10.3M | $10.6M | $10.3M |
| Goodwill & intangible assets | $14.3M | $14.3M | $14.9M | $15.4M | $16.2M | $16.2M | $16.4M | $17.6M | $17.5M | $18.0M | $18.6M | $19.1M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $1 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $124.6M | $124.4M | $122.5M | $122.0M | $120.8M | $122.5M | $122.5M | $129.7M | $130.0M | $135.4M | $135.5M | $131.2M |
| Liabilities | ||||||||||||
| Accounts payable | $876,000 | $1.2M | $911,000 | $768,000 | $737,000 | $914,000 | $696,000 | $999,000 | $834,000 | $998,000 | $769,000 | $511,000 |
| Short-term debt | — | — | — | — | — | — | $56,000 | — | — | — | $47,000 | — |
| Deferred revenue | — | — | — | — | — | — | — | — | — | — | $327,000 | — |
| Total current liabilities | $2.1M | $3.5M | $2.6M | $3.0M | $2.3M | $4.3M | $3.8M | $3.4M | $3.9M | $5.5M | $4.7M | $4.2M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $195,000 | $210,000 | $225,000 | $241,000 | $256,000 | $269,000 | $282,000 | $299,000 | $275,000 | $285,000 | $295,000 | $305,000 |
| Other long-term liabilities | $469,000 | $504,000 | $676,000 | $711,999 | $1.0M | $1.1M | $1.4M | $2.1M | $2.0M | $2.2M | $2.4M | $3.4M |
| Total liabilities | $2.5M | $4.0M | $3.3M | $3.7M | $3.3M | $5.5M | $5.1M | $5.5M | $6.0M | $7.7M | $7.1M | $7.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $32,000 | $32,000 | $32,000 | $32,000 | $32,000 | $33,000 | $33,000 | $34,000 | $35,000 | $36,000 | $36,000 | $36,000 |
| Retained earnings (deficit) | $132.0M | $130.3M | $128.7M | $128.0M | $126.9M | $128.2M | $129.3M | $134.1M | $135.3M | $139.0M | $138.3M | $135.1M |
| Accumulated other comprehensive income | −$10.0M | −$9.9M | −$9.4M | −$9.7M | −$9.4M | −$11.2M | −$11.9M | −$9.9M | −$11.3M | −$11.3M | −$10.7M | −$12.0M |
| Total shareholders' equity | $122.0M | $120.4M | $119.3M | $118.3M | $117.5M | $117.0M | $117.4M | $124.2M | $124.1M | $127.7M | $128.3M | $123.7M |
| Key figures | ||||||||||||
| Total debt | $195,000 | $210,000 | $225,000 | $241,000 | $256,000 | $269,000 | $282,000 | $299,000 | $275,000 | $285,000 | $295,000 | $305,000 |
| Net cash (debt) | $87.3M | $87.2M | $85.5M | $84.0M | $81.9M | $83.1M | $82.7M | $88.2M | $88.9M | $93.5M | $92.6M | $87.9M |
| Working capital | $98.6M | $96.9M | $95.1M | $93.5M | $92.1M | $92.1M | $92.6M | $98.2M | $98.4M | $101.7M | $101.6M | $97.7M |
| Tangible book value | $107.7M | $106.1M | $104.4M | $102.8M | $101.4M | $100.9M | $101.0M | $106.6M | $106.5M | $109.7M | $109.7M | $104.7M |
| Book value per share | $38.33 | $37.79 | $37.29 | $36.87 | $36.21 | $35.36 | $34.66 | $35.71 | $35.12 | $35.31 | $35.36 | $33.99 |
| Shares outstanding | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.3M | 3.4M | 3.5M | 3.5M | 3.6M | 3.6M | 3.6M |
| Current ratio | 48.62 | 28.64 | 37.62 | 32.06 | 41.87 | 22.29 | 25.64 | 29.59 | 25.98 | 19.57 | 22.56 | 24.38 |
| Quick ratio | 44.01 | 25.97 | 34.36 | 29.22 | 38.07 | 20.18 | 23.18 | 26.83 | 23.58 | 17.79 | 20.44 | 21.95 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity / assets | 98.0% | 96.8% | 97.3% | 96.9% | 97.3% | 95.5% | 95.8% | 95.8% | 95.4% | 94.3% | 94.7% | 94.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 27, 2026); data from EODHD.
UTMD financial position
At the end of fiscal 2025 (December 31, 2025), Utah Medical Products had total assets of $122.5 million (up 0.0% from a year earlier), total liabilities of $3.3 million and shareholders' equity of $119.3 million. It held $85.8 million in cash and short-term investments against $0.2 million of debt, a net cash position of $85.5 million. Its current ratio was 37.62. In the latest quarter (ended June 30, 2026) total assets were $124.6 million and equity $122.0 million.
Related: UTMD income statement, UTMD cash flow statement, UTMD key metrics. See the UTMD stock overview for the latest quote and news.
UTMD balance sheet FAQ
What are Utah Medical Products's total assets?
Utah Medical Products reported total assets of $122.5 million at the end of fiscal 2025 (December 31, 2025), compared with $122.5 million a year earlier.
How much debt does Utah Medical Products have?
Utah Medical Products had $0.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.00.
How much cash does Utah Medical Products have?
Utah Medical Products held $85.8 million in cash and short-term investments at the end of fiscal 2025; with $0.2 million of debt that is net cash of $85.5 million.
What is Utah Medical Products's book value?
Utah Medical Products's shareholders' equity (book value) was $119.3 million at the end of fiscal 2025, or $36.81 per share.
What is Utah Medical Products's current ratio?
Utah Medical Products had current assets of $97.7 million and current liabilities of $2.6 million, a current ratio of 37.62 (it can cover its short-term obligations).
How much goodwill does Utah Medical Products have?
Utah Medical Products carried $14.9 million of goodwill and intangible assets, 12.2% of total assets, at the end of fiscal 2025.